Ravi, J., Sneh, A., Shilo, K., Nasser, M. W., & Ganju, R. K. (2014). FAAH inhibition enhances anandamide mediated anti-tumorigenic effects in non-small cell lung cancer by downregulating the EGF/EGFR pathway. Impact Journals LLC.
Styl cytowania ChicagoRavi, Janani, Amita Sneh, Konstantin Shilo, Mohd W. Nasser, i Ramesh K. Ganju. FAAH Inhibition Enhances Anandamide Mediated Anti-tumorigenic Effects in Non-small Cell Lung Cancer By Downregulating the EGF/EGFR Pathway. Impact Journals LLC, 2014.
Styl cytowania MLARavi, Janani, et al. FAAH Inhibition Enhances Anandamide Mediated Anti-tumorigenic Effects in Non-small Cell Lung Cancer By Downregulating the EGF/EGFR Pathway. Impact Journals LLC, 2014.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..